Table 1.
Clinical and laboratory characteristics of the patients with hepatocellular carcinoma, n (%)
| Characteristics | Value |
| Patient number | 91 |
| Gender | |
| Women | 17 (18.7) |
| Men | 74 (81.3) |
| Age in yr, mean ± SD | 67.91 ± 8.98 |
| Etiology | |
| Alcohol abuse | 41 (45.1) |
| Viral hepatitis | 12 (13.2) |
| NASH | 13 (14.3) |
| Hemochromatosis | 6 (6.6) |
| Rare or other cause | 19 (20.8) |
| BCLC stage | |
| 0 | 0 (0.0) |
| A | 16 (17.6) |
| B | 37 (40.6) |
| C | 32 (35.2) |
| D | 6 (6.6) |
| Child-Pugh score | |
| No liver cirrhosis | 16 (17.6) |
| A | 45 (49.4) |
| B | 27 (29.7) |
| C | 3 (3.3) |
| Treatment | |
| Therapy naive | 26 (28.6) |
| Pretreated | 65 (71.4) |
NASH: Non-alcoholic steatohepatitis; BCLC: Barcelona clinic liver cancer.